Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections and Current Research Trends
University of Kansas, Lawrence, KS-66045, USA
Biography:
Dr. Rao Gollapudi has been retired from the University of Kansas in 2012. Before that, he worked as a researcher and faculty member in the medicinal chemistry department of KU (1980-1991) and as a research scientist at KU (2010-2012), and as a technical adviser to Oread Laboratories. Furthermore, he worked as a director at Geneva Laboratories, Inc. Wisconsin, Manager in ABC Laboratories, Inc. Columbia, MO, Systems Administrator in PPD, and Vice-President of Research and Development of Dynarx Technology, Inc., Lawrence. And he is experienced in chemotherapy, cell biology, drug discovery, and synthesis & natural products chemistry.
Subjects of specialization: Medicinal Chemistry, cell biology, drug discovery and synthesis, natural products chemistry, chemotherapy